In Phase II Clinical Trials
Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.
Hub Controls
  • Demo Video
  • Upload Photo
  • Edit Company Profile
  • Add a Link
  • Update Fast Facts
  • Add Management Bios
  • Private Messages
  • Edit My Profile
  • View/Edit My Portfolio

Email Updates

Search
AlphaRx > Message
Generic_profile

Re: NEWS - AlphaRx Announces Selection of ARX828, a Novel iNOS inhibitor, for Advanced Preclinical Development

Posted by: Tutty on September 13, 2007 04:12PM

In response to: NEWS - AlphaRx Announces Se... by AGORACOM

This should be an interesting one. Hopefully this should turn out to be a lot better than indaflex one. The IBD doesn't sound too pleasing :P  eeeesh
Did You Know?

AGORACOM members with a rank of Vice President or higher can update Company Profiles

Log in to Recommend Up_g

0 members recommend this.

Post a Reply

Please login to reply to this message.

Subscribe to Rss Feed
Executive Address
Alrxsmall
Michael Lee
President
May 18, 2006

 

Michael Lee provides the investor community an update on recent events

View Broadcast

Stock Quote
Open alrx Stock Quote